Ruben Rizzi

Company: BioNTech

Job title: SVP Global Regulatory Affairs

Seminars:

mRNA-based cancer immunotherapies: an evolving regulatory landscape 4:30 pm

• BioNTech´s oncology pipeline: combining different modalities to address the continuum of cancer treatment • The regulatory classification of mRNA-based medicinal products • The specific challenges of fully individualized mRNA-based therapiesRead more

day: Conference Day Two